Stockreport

BridgeBio Pharma Reports Third Quarter 2024 Financial Results and Business Update

BridgeBio Pharma, Inc.  (BBIO) 
Last bridgebio pharma, inc. earnings: 3/2 08:29 am Check Earnings Report
PDF - Patients on acoramidis, a near complete (=90%) TTR stabilizer in clinical development, lived longer and better as shown in the ATTRibute-CM study. This is the only Pha [Read more]